Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
					Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





Uranium (insoluble compounds, as U)																				Related Pages
										May 1994
Immediately Dangerous to Life or Health Concentrations (IDLH)
**CAS number:** 7440–61–1 (Metal)
**NIOSH REL:** 0.2 mg/m3 TWA, 0.6 mg/m3 STEL; NIOSH considers insoluble uranium compounds to be a potential occupational carcinogens as defined by the OSHA carcinogen policy [29 CFR 1990].
**Current OSHA PEL:** 0.25 mg/m3 TWA
**1989 OSHA PEL:** 0.2 mg/m3 TWA, 0.6 mg/m3 STEL
**1993-1994 ACGIH TLV:** 0.2 mg/m3 TWA, 0.6 mg/m3 STEL
**Description of substance:** Varies
**Original (SCP) IDLH:** 30 mg U/m3
**Basis for original (SCP) IDLH:** ILO [1972] stated that “insoluble compounds tend to be deposited and retained in tissues and organs for long periods. Prolonged irradiation of the thorax, at sites of uranium accumulation, may eventually result in osteosarcoma and pulmonary cancer. Experimental inhalations of uranium oxide (31 to 91 mg/m3) for 5 days led to the appearance of pneumosclerosis 16 months later at points where alpha-tracks were concentrated. After 22 to 23 months, there was hyperplasia of the bronchial epithelium, and, after 56 months, lung cancer was diagnosed.” Both the chemical and radioactive properties of the metal must be considered.
**Short-term exposure guidelines:** None developed
**ACUTE TOXICITY DATA:**
**Animal data:** Inhalation of 31 to 91 mg/m3 of uranium oxide for 5 days led to the appearance of pneumosclerosis 16 months later at points where alpha-tracks were concentrated; after 22 to 23 months, there was hyperplasia of the bronchial epithelium, and, after 56 months, lung cancer was diagnosed [ILO 1972].
**Human data:** None relevant for use in determining the revised IDLH.

**Revised IDLH:** 10 mg U/m3**Basis for revised IDLH:** The revised IDLH for insoluble uranium compounds is 10 mg U/m3 based on subchronic inhalation toxicity data in animals [ILO 1972] and to be consistent with soluble uranium compounds which have a revised IDLH of 10 mg U/m3. [Note: NIOSH recommends as part of its carcinogen policy that the "most protective" respirators be worn for insoluble uranium compounds at concentrations above 0.2 mg/m3.]**REFERENCE:**
1. ILO [1972]. Uranium, alloys, compounds. In: Encyclopaedia of occupational health and safety. 2nd ed. Vol. II (L-Z). Geneva, Switzerland: International Labour Office, pp. 1452-1454.

			
							
								Page last reviewed:  December 4, 2014						Content
							source: 	National Institute for Occupational Safety and Health NIOSH Publications & Products
Immediately Dangerous To Life or Health (IDLH) Values
Table of IDLH Values
Criteria for Determining IDLH Values
Historical Documentation
Original (SCP) Values
Abbreviations for IDLH Documentation
Abbreviations for Journal Titles Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification/Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
					Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
					You will be subject to the destination website's privacy policy when you follow the link.
					CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue